-
The Impact of Research Sessions on Pharmacy Students’ Perceived Understanding in Research Design and Methodology
Mar 10, 2025, 14:00 PM -
An Economic Model Exploring the Impact of Formulary Restrictions on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants in the United States
Mar 10, 2025, 14:00 PM -
Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)
Mar 10, 2025, 14:00 PM -
Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China
Mar 10, 2025, 14:00 PM -
Emerging Trends in AI Applications: Shaping Pharmacoepidemiology and Health Technology Assessments
Mar 10, 2025, 14:00 PM -
Economic and Environmental Impact of Decentralized Cancer Care (DCC) in Oncology: An Innovative Experience in the French Alps
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Evaluation of Adherence to Clinical Protocol and Therapeutic Guidelines (PCDT) for Mucopolysaccharidosis Type 2 (MPS2) at Codajás Polyclinic - An Analysis of the Value-Based Care Journey
Mar 10, 2025, 14:00 PM -
Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval
Mar 10, 2025, 14:00 PM -
Quality of Life Assessment of Patients Undergoing Hip Replacement Surgery in the Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life in Individuals with Diagnosed Depression, Self-Reported Depression, and Non-Depressed: A Multi-Center Cross-Sectional Study
Mar 10, 2025, 14:00 PM -
Estimation of Drug Cost Reductions by Introducing formularies for An Employment-based Health Insurance Plan : A Simulation Using “Wellness-Star☆” Health Insurance Claims Database
Mar 10, 2025, 14:00 PM -
Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications
Mar 10, 2025, 14:00 PM -
Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value
Mar 10, 2025, 14:00 PM -
The Prevalence Of Multi-Comorbid Patients In The US: The Potential For Benefit Being Greater Than Bargained For And The Need For Multi-Indication Value Assessment
Mar 10, 2025, 14:00 PM -
Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database
Mar 10, 2025, 14:00 PM -
Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States
Mar 10, 2025, 14:00 PM -
Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations
Mar 10, 2025, 14:00 PM -
Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study
Mar 10, 2025, 14:00 PM
